Page last updated: 2024-11-05

trihexyphenidyl and Apraxia

trihexyphenidyl has been researched along with Apraxia in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Krack, P	1
Marion, MH	1
Klostermann, W	1
Vieregge, P	1
Kömpf, D	1

Other Studies

2 other studies available for trihexyphenidyl and Apraxia

Article	Year
"Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patients. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Apraxias; Blepharospasm; Botulinum Toxins; Dose-Response Relationshi	1994
Apraxia of eyelid opening after bilateral stereotaxic subthalamotomy. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1997, Volume: 17, Issue:2 Topics: Adult; Antiparkinson Agents; Apraxias; Blinking; Dystonia Musculorum Deformans; Eyelid Diseases; Hum	1997